Skip to main content

PLANIFICACION DEL ALTA DESDE URGENCIAS PARA REDUCIR REINGRESOS A 30 DIAS EN MAYORES FRAGILES CON INSUFICIENCIA CARDIACA AGUDA: ENSAYO CLINICO ALEATORIZADO POR CONGLOMERADOS PAREADO.

PI18/00456

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2018
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INVESTIGACION BIOMEDICA HOSPITAL CLINICO SAN CARLOS
Execution centre INSTITUTO DE INVESTIGACION SANITARIA DEL HOSPITAL CLINICO SAN CARLOS (IdISSC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Timing of previous heart failure hospitalization as a prognostic factor for emergency department heart failure patients

  • Romero, Carlos|||0009-0002-1803-6303
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Herrera, Sergio|||0000-0001-6134-0402
  • Llorens, Pere
  • Gil, Víctor
  • Curtelin, David
  • Jacob, Javier|||0000-0003-1101-1066
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • María Pilar Lopez Díez
  • Llauger, Lluis
  • Luisa López Grima, M.
  • Gil, Cristina
  • Tost, Josep|||0000-0003-3846-9616
  • Agüera Urbano, Carmen
  • Espinosa, Begoña
  • Campos-Meneses, Maria
  • Fernandez, G
  • Torres, A.
  • Escoda, Rosa
  • Martín, Enrique
  • Garrido, Jose Manuel
  • Lucas-Imbernon, Francisco Javier
  • Rodríguez-Adrada, Esther
  • Torres Gárate, Raquel|||0000-0002-8731-9350
  • Andueza, Juan Antonio
  • Peacock, W. Frank
  • Miró, Oscar|||0000-0002-7924-9751
To investigate whether the timing of a previous hospital admission for acute heart failure (AHF) is a prognostic factor for AHF patients revisiting the emergency department (ED) in the subsequent 12-month follow-up. All ED AHF patients enrolled in the previously described EAHFE registry were stratified by the presence or absence of an AHF hospitalization admission in the prior 12 months. The primary outcome was 12-month all-cause mortality post ED visit. Secondary end points were hospital admission, prolonged hospitalization (> 7 days), mortality during hospitalization and a 90-day post-discharge adverse composite event (ACE) rate, defined as ED revisits due to AHF, hospitalizations due to AHF, or all-cause mortality. Outcomes were adjusted for baseline and AHF episode characteristics.Of 5,757 patients included, the median age was 84 years (IQR 77-88); 57% were women, and 3,759 (65.3%) had an AHF hospitalization in the previous 12 months. The 12-month mortality was 37% (41.7% vs. 28.3% p < 0.001), hospital admission was 76.1% (78.8% vs. 71.1% p < 0.001) ACE was 60.2% (65.1% vs. 50.5% p < 0.001). In the adjusted analysis, patients with AHF hospitalization in the prior 12 months had a higher mortality (HR = 1.41; 95% CI 1.27-1.56), 90-day ACE rate (HR = 1.45: 95% CI 1.32-1.59), and more hospital admissions (OR = 1.32; 95% CI 1.16-1.51), with shorter times since the previous hospitalization being related to the outcomes analyzed. One-year mortality, adverse events at 90 days, and readmission rates are increased in ED AHF patients previously admitted within the last 12 months.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes

  • Javaloyes, P.
  • Miro, O.
  • Gil, V.
  • Martin-Sanchez, F.J.
  • Jacob, J.
  • Herrero, P.
  • Takagi, K.
  • Alquezar-Arbe, A.
  • Diez, M.P.L.
  • Martin, E.
  • Bibiano, C.
  • Escoda, R.
  • Gil, C.
  • Fuentes, M.
  • Garcia, G.L.
  • Perez, J.M.A.
  • Jerez, A.
  • Tost, J.
  • Llauger, L.
  • Romero, R.
  • Garrido, J.M.
  • Rodriguez-Adrada, E.
  • Sanchez, C.
  • Rossello, X.
  • Parissis, J.
  • Mebazaa, A.
  • Chioncel, O.
  • Llorens, P.
  • Alonso, H.
  • Perez-Llantada, E.
  • Cadenas, M.S.
  • Xipell, C.
  • Perez-Dura, M.J.
  • Salvo, E.
  • Pavon, J.
  • Noval, A.
  • Torres, J.M.
  • Lopez-Grima, M.L.
  • Valero, A.
  • Juan, M.A.
  • Aguirre, A.
  • Pedragosa, M.A.
  • Maso, S.M.
  • Alonso, M.I.
  • Ruiz, F.
  • Franco, J.M.
  • Mecina, A.B.
  • Berenguer, M.
  • Donea, R.
  • Ramon, S.S.
  • Rodriguez, V.C.
  • Pinera, P.
  • Nicolas, J.A.S.
  • Garate, R.T.
  • Rizzi, M.A.
  • Herrera, S.
  • Cabello, I.
  • Haro, A.
  • Richard, F.
  • Diez, M.P.L.
  • Alvarez, J.V.
  • Garcia, B.P.
  • Garcia, M.G.
  • Gonzalez, M.S.
  • Marquina, V.
  • Jimenez, I.
  • Hernandez, N.
  • Brouzet, B.
  • Espinosa, B.
  • Andueza, J.A.
  • Ruiz, M.
  • Calvache, R.
  • Serralta, M.T.L.
  • Jave, L.E.C.
  • Amores Arriaga, B.
  • Bergua, B.S.
  • Mojarro, E.M.
  • Jimenez, B.S.A.
  • Becquer, L.T.
  • Burillo, G.
  • Garcia, L.L.
  • LaSalle, G.C.
  • Urbano, C.A.
  • Soto, A.B.G.
  • Padial, E.D.
  • Ferrer, E.S.
  • Lucas-Imbernon, F.J.
  • Gaya, R.
  • Mir, M.
  • Rodriguez, B.
  • Carballo, J.L.
  • Miranda, B.R.
Objective To compare the clinical characteristics and outcomes of patients with acute heart failure (AHF) according to clinical profiles based on congestion and perfusion determined in the emergency department (ED). Methods and results Overall, 11 261 unselected AHF patients from 41 Spanish EDs were classified according to perfusion (normoperfusion = warm; hypoperfusion = cold) and congestion (not = dry; yes = wet). Baseline and decompensation characteristics were recorded as were the main wards to which patients were admitted. The primary outcome was 1-year all-cause mortality; secondary outcomes were need for hospitalisation during the index AHF event, in-hospital all-cause mortality, prolonged hospitalisation, 7-day post-discharge ED revisit for AHF and 30-day post-discharge rehospitalisation for AHF. A total of 8558 patients (76.0%) were warm+ wet, 1929 (17.1%) cold+ wet, 675 (6.0%) warm+ dry, and 99 (0.9%) cold+ dry; hypoperfused (cold) patients were more frequently admitted to intensive care units and geriatrics departments, and warm+ wet patients were discharged home without admission. The four phenotypes differed in most of the baseline and decompensation characteristics. The 1-year mortality was 30.8%, and compared to warm+ dry, the adjusted hazard ratios were significantly increased for cold+ wet (1.660; 95% confidence interval 1.400-1.968) and cold+ dry (1.672; 95% confidence interval 1.189-2.351). Hypoperfused (cold) phenotypes also showed higher rates of index episode hospitalisation and in-hospital mortality, while congestive (wet) phenotypes had a higher risk of prolonged hospitalisation but decreased risk of rehospitalisation. No differences were observed among phenotypes in ED revisit risk. Conclusions Bedside clinical evaluation of congestion and perfusion of AHF patients upon ED arrival and classification according to phenotypic profiles proposed by the latest European Society of Cardiology guidelines provide useful complementary information and help to rapidly predict patient outcomes shortly after ED patient arrival.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Influence of the length of hospitalisation in post-discharge outcomes in patients with acute heart failure: Results of the LOHRCA study

  • Miró, Ò.
  • Padrosa, J.
  • Takagi, K.
  • Gayat, É.
  • Gil, V.
  • Llorens, P.
  • Martín-Sánchez, F.J.
  • Herrero-Puente, P.
  • Jacob, J.
  • Montero, M.M.
  • Tost, J.
  • Díez, M.P.L.
  • Traveria, L.
  • Torres-Gárate, R.
  • Alonso, M.I.
  • Agüera, C.
  • Valero, A.
  • Javaloyes, P.
  • Peacock, W.F.
  • Bueno, H.
  • Mebazaa, A.
  • Fuentes, M.
  • Gil, C.
  • Alonso, H.
  • Garmila, P.
  • García, G.L.
  • Yáñez-Palma, M.C.
  • López, S.I.
  • Escoda, R.
  • Xipell, C.
  • Sánchez, C.
  • Gaytan, J.M.
  • Pérez-Durá, M.J.
  • Salvo, E.
  • Pavón, J.
  • Noval, A.
  • Torres, J.M.
  • López-Grima, M.L.
  • Juan, M.Á.
  • Aguirre, A.
  • Morales, J.E.
  • Masó, S.M.
  • Ruiz, F.
  • Franco, J.M.
  • Mecina, A.B.
  • Sánchez, S.
  • Carbajosa, V.
  • Piñera, P.
  • Nicolás, J.A.S.
  • Garate, R.T.
  • Alquezar, A.
  • Rizzi, M.A.
  • Herrera, S.
  • Roset, A.
  • Cabello, I.
  • Richard, F.
  • Pérez, J.M.Á.
  • Diez, M.P.L.
  • Álvarez, J.V.
  • García, B.P.
  • Sánchez González, M.G.G.Y.
  • Marquina, V.
  • Jiménez, I.
  • Hernández, N.
  • Brouzet, B.
  • Ramos, S.
  • López, A.
  • Andueza, J.A.
  • Romero, R.
  • Ruíz, M.
  • Calvache, R.
  • Lorca, M.T.
  • Calderón, L.
  • Arriaga, B.A.
  • Sierra, B.
  • Mojarro, E.M.
  • Bécquer, L.T.
  • Burillo, G.
  • García, L.L.
  • LaSalle, G.C.
  • Urbano, C.A.
  • Soto, A.B.G.
  • Padial, E.D.
  • Ferrer, E.S.
  • Garrido, M.
  • Lucas, F.J.
  • Gaya, R.
  • Bibiano, C.
  • Mir, M.
  • Rodríguez, B.
  • Sánchez, N.
  • Carballo, J.L.
  • Rodríguez-Adrada, E.
  • Rodríguez, B.
Objective: To investigate the relationship between length of hospitalisation (LOH) and post-discharge outcomes in acute heart failure (AHF) patients and to ascertain whether there are different patterns according to department of initial hospitalisation. Methods: Consecutive AHF patients hospitalised in 41 Spanish centres were grouped based on the LOH (<6/6-10/11-15/>15 days). Outcomes were defined as 90-day post-discharge all-cause mortality, AHF readmissions, and the combination of both. Hazard ratios (HRs), adjusted by chronic conditions and severity of decompensation, were calculated for groups with LOH >6 days vs. LOH <6 days (reference), and stratified by hospitalisation in cardiology, internal medicine, geriatrics, or short-stay units. Results: We included 8563 patients (mean age: 80 (SD = 10) years, 55.5% women), with a median LOH of 7 days (IQR 4–11): 2934 (34.3%) had a LOH <6 days, 3184 (37.2%) 6–10 days, 1287 (15.0%) 11–15 days, and 1158 (13.5%) >15 days. The 90-day post-discharge mortality was 11.4%, readmission 32.2%, and combined endpoint 37.4%. Mortality was increased by 36.5% (95%CI = 13.0–64.9) when LOH was 11–15 days, and by 72.0% (95%CI = 42.6–107.5) when >15 days. Conversely, no differences were found in readmission risk, and the combined endpoint only increased 21.6% (95%CI = 8.4–36.4) for LOH >15 days. Stratified analysis by hospitalisation departments rendered similar post-discharge outcomes, with all exhibiting increased mortality for LOH >15 days and no significant increments in readmission risk. Conclusions: Short hospitalisations are not associated with worse outcomes. While post-discharge readmissions are not affected by LOH, mortality risk increases as the LOH lengthens. These findings were similar across hospitalisation departments.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation

  • Tost, Josep|||0000-0003-3846-9616
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Cotter, Gad|||0000-0002-9613-3339
  • Davison, Beth A.
  • Jacob, Javier|||0000-0003-1101-1066
  • Gil, Víctor
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Donea, Ruxandra
  • Rodríguez, Beatriz|||0000-0002-0402-3838
  • Lucas-Imbernon, Francisco Javier
  • Andueza, Juan Antonio
  • Mecina, Ana Belén
  • Torres Gárate, Raquel|||0000-0002-8731-9350
  • Piñera, Pascual|||0000-0001-9213-9357
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Espinosa, Bego|||0000-0001-9531-6451
  • Mebazaa, A.
  • Chioncel, O.|||0000-0002-3197-3628
  • Miró, Oscar|||0000-0002-7924-9751
Aims: To analyze the frequency with which patients with heart failure with preserved ejection fraction (HFpEF) discharged after an acute heart failure (AHF) episode are treated with antineurohormonal drugs (ANHD), the variables related to ANHD prescription and their relationship with outcomes. Methods: We included consecutive HFpEF patients (left ventricular ejection fraction ≥50%) discharged after an AHF episode from 45 Spanish hospitals whose chronic medications and treatment at discharge were available. Patients were classified according to whether they were discharged with or without ANHD, including beta-blockers (BB), renin-angiotensin-aldosterone-system inhibitors (RAASi) and mineralcorticosteroid-receptor antagonists (MRA). Co-primary outcomes consisted of 1-year all-cause mortality and 90-day combined adverse event (revisit to emergency department -ED-, hospitalization due to AHF or all-cause death). Secondary outcomes were 90-day adverse events taken individually. Adjusted associations of ANHD treatment with outcomes were calculated. Results: We analyzed 3,305 patients with HFpEF (median age: 83, 60% women), 2,312 (70%) discharged with ANHD. The ANHD most frequently prescribed was BB (45.8%). The 1-year mortality was 26.9% (adjusted HR for ANHD patients:1.17, 95%CI=0.98-1.38) and the 90-day combined adverse event was 54.4% (HR=1.14, 95%CI=0.99-1.31). ED revisit was significantly increased by ANHD (HR=1.15, 95%CI=1.01-1.32). MRA and BB were associated with worse results in some co-primary or secondary endpoints, while RAASi (alone) reduced 90-day hospitalization (HR=0.73, 98%CI=0.56-0.96). Conclusion: 70% of HFpEF patients are discharged with ANHD after an AHF episode. ANHD do not seem to reduce mortality or adverse events in HFpEF patients, only RAASi could provide some benefits, reducing the risk of hospitalization for AHF.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure, Insights from the EAHFE Spanish registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Freund, Yonathan
  • Davison, Beth A.
  • Takagi, Koji
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Gil, Víctor
  • Rossello, Xavier|||0000-0001-6783-8463
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Jiménez-Fábrega, Francesc X.
  • Masip, Josep|||0000-0002-8612-9889
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Cotter, Gad|||0000-0002-9613-3339
Background and objective: Although recommended for the treatment of acute heart failure (AHF), the use of intravenous (IV) nitroglycerin (NTG) is supported by scarce and contradicting evidence. In the current analysis, we have assessed the impact of IV NTG administration by EMS or in emergency department (ED) on outcomes of AHF patients. Methods: We analyze AHF patients included by 45 hospitals that were delivered to ED by EMS. Patients were grouped according to whether treatment with IV NTG was started by EMS before ED admission (preED-NTG), during the ED stay (ED-NTG) or were untreated with IV NTG (no-NTG, control group). In-hospital, 30-day and 365-day all-cause mortality, prolonged hospitalization (.